MCAD deficiency, named after Medium-Chain Acyl-Coenzyme A Dehydrogenase, is an inherited and rare genetic disorder that prevents the body from breaking down certain fats and turning them into energy. MCAD affects approximately 1 in 15,000 babies in the United States.

Babies are screened and diagnosed with this rare condition typically just days after they are born. People with this deficiency must eat more meals every day compared to most other people. Without consistent and nutritious meals, a child or adult with this condition would not have enough energy to make it through the day.

This Commonwealth is fortunate to have programs focused on metabolic diseases in multiple hospitals across the state. The Metabolic Disease Program at the Children’s Hospital of Philadelphia (CHOP) and the Center for Rare Disease Therapy at UPMC Children’s Hospital of Pittsburgh provide diagnostic and treatment services to children with genetic metabolic disorders, including MCAD.

I am introducing a resolution to designate October 20, 2026 as MCAD Awareness Day in Pennsylvania to create further awareness and ensure that research continues for MCAD deficiency. Please join me in co-sponsoring this resolution.